Israeli medical robotic company Mazor Robotics will be acquired by Dublin-based Medtronic in a deal worth approximately $1.64 billion, the companies announced.
The deal, which the Irish firm announced Thursday, represents the largest sale or “exit” of an Israeli medical company to date, surpassing the $1.1 billion acquisition of NeuroDerm by Mitsubishi Tanabe Pharma in 2017, according to The Jerusalem Post.
Founded in 2001, Caesarea-based Mazor Robotics has pioneered the application of robotics technology and guidance for use in spinal procedures. The company has over 50 patents to its name.
Read more at Arutz Sheva.